Several analysts have recently updated their ratings and price targets for Sartorius (FRA: SRT3):

  • 2/5/2019 – Sartorius was given a new €90.00 ($104.65) price target on by analysts at Nord/LB. They now have a “sell” rating on the stock.
  • 2/5/2019 – Sartorius was given a new €116.00 ($134.88) price target on by analysts at HSBC Holdings plc. They now have a “neutral” rating on the stock.
  • 1/29/2019 – Sartorius was given a new €107.00 ($124.42) price target on by analysts at Kepler Capital Markets. They now have a “sell” rating on the stock.
  • 1/29/2019 – Sartorius was given a new €110.00 ($127.91) price target on by analysts at Berenberg Bank. They now have a “neutral” rating on the stock.
  • 1/29/2019 – Sartorius was given a new €142.00 ($165.12) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 1/29/2019 – Sartorius was given a new €141.00 ($163.95) price target on by analysts at Warburg Research. They now have a “buy” rating on the stock.
  • 12/13/2018 – Sartorius was given a new €142.00 ($165.12) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.

Shares of SRT3 traded up €5.30 ($6.16) during mid-day trading on Monday, hitting €139.20 ($161.86). 50,508 shares of the company’s stock were exchanged. Sartorius AG has a fifty-two week low of €71.00 ($82.56) and a fifty-two week high of €124.70 ($145.00).

Sartorius Aktiengesellschaft provides pharmaceutical and laboratory equipment worldwide. The company operates through two divisions, Bioprocess Solutions, and Lab Products & Services. The Bioprocess Solutions division offers products, technologies, and services ranging from fermentation, cell cultivation, filtration, and purification to media storage and transportation for the biopharmaceutical industry.

Recommended Story: Understanding Options Trading

Receive News & Ratings for Sartorius AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius AG and related companies with MarketBeat.com's FREE daily email newsletter.